Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri provide an overview of nasal polyposis, its symptoms, and its risk factors.

Andrew White, MD, and Dareen Siri, MD, FAAAAI, FACAAI, discuss the comorbidities chronic rhinosinusitis with nasal polyps (CRSwNP) can be associated with.

An expert panel discusses a multidisciplinary approach to the diagnosis and management of nasal polyposis.

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri review guidelines and position statements for diagnosis and management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Chronic Rhinosinusitis without Nasal Polyps (CRSsNP).

Dareen Siri, MD, FAAAAI, FACAAI, discusses the treatment options available for Nasal Polyposis.

Dareen Siri, MD, FAAAAI, FACAAI, highlights small volume corticosteroid delivery systems for patients with nasal polyps and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Andrew White, MD, reviews large volume corticosteroid delivery devices for patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Naveen Bhandarkar, MD, discusses the use of sinus implants for the treatment of nasal polyposis.

Naveen Bhandarkar, MD, shares his thoughts on the role of steroid eluting stents in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Expert allergists provide an overview of the phase 3 studies with EDS-FLU for treatment of nasal polyposis.

Drs Anju Peters and Naveen Bhandarkar comment on the use of steroids after surgery for nasal polyposis.

A multidisciplinary panel discusses the role of EDU-FLU in their individual practices.

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri discuss their approach to changing treatment for patients with chronic rhinosinusitis either with or without nasal polyps.

A panel of experts highlights the role of biologics in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Drs Anju Peters and Naveen Bhandarkar, comment on the challenges of using biologic therapies to treat patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP).

Drs Anju Peters and Naveen Bhandarkar, comment on the challenges of using biologic therapies to treat patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP).

A multidisciplinary panel reviews emerging treatment options for nasal polyposis, including EDS-FLU, Tezepelumab, and Rimegepant.

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri review unmet needs and shared decision making in the treatment of nasal polyposis.

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.